Fatemeh Baharvand, Roxana Mehran, Francesca Maria Di Muro, Alieh Mohammadi, Mohammadreza Aghajankhah, Shiva Parvaneh et al. Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes. // American Journal of Cardiovascular Drugs. – 2026. – DOI: 10.1007/s40256-026-00814-8. – URL: https://doi.org/10.1007/s40256-026-00814-8
Fatemeh Baharvand, Roxana Mehran, Francesca Maria Di Muro, Alieh Mohammadi, Mohammadreza Aghajankhah, Shiva Parvaneh, Niloufar Akbari Parsa, Soheil Hassanipour, Ehsan Aboutaleb, Yaser Jenab, & Somayeh Bashiri Aliabadi (2026). Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes. American Journal of Cardiovascular Drugs. https://doi.org/10.1007/s40256-026-00814-8
Fatemeh Baharvand, et al. “Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes.” American Journal of Cardiovascular Drugs, 2026. doi:10.1007/s40256-026-00814-8.
@article{Baharvand2026,
title = {Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes},
author = {Baharvand, Fatemeh and Mehran, Roxana and Muro, Francesca Maria Di and Mohammadi, Alieh and Aghajankhah, Mohammadreza and Parvaneh, Shiva and Parsa, Niloufar Akbari and Hassanipour, Soheil and Aboutaleb, Ehsan and Jenab, Yaser and Aliabadi, Somayeh Bashiri},
journal = {American Journal of Cardiovascular Drugs},
year = {2026},
doi = {10.1007/s40256-026-00814-8},
url = {https://doi.org/10.1007/s40256-026-00814-8}
}